(Q46597609)

English

Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?

scientific article published on 13 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma? (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

1 reference

based on heuristic

inferred from title

author name string

Madhav V Dhodapkar

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

Dennis L Cooper

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

publication date

13 May 2008

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

Nature Clinical Practice Oncology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

372-373

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1138

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1138

7 January 2021

based on heuristic

inferred from DOI database lookup

The malignant clone and the bone-marrow environment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1138

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1138

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCPONC1138

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18477992

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46597609&oldid=1458706329"